Prof. Dr. med. Lukas Flatz
Oberarzt und Gruppenleiter
Oberarzt/Oberärztin
Dermatologie | Venerologie | Allergologie · Dept. Interdisziplinäre Medizinische Dienste
T002-080413-9 Version 2, 27 May 2020 Page 1 of 68 CLINICAL STUDY PROTOCOL PH-L19IL2TNFNMSC-04/19 A phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions
02.08.2020
Klinische Forschung - 02.08.2020 - 25.01.2030
Laufend
Projektleitung: Flatz Lukas
Immunmonitoring of patients before, during and after immunotherapy to predict anti-tumor response in melanoma and non-small cell lung cancer (IMIT)
15.07.2016
Klinische Forschung - 15.07.2016 - 15.10.2019
Automatisch geschlossen
Projektleitung: Flatz Lukas
Mitarbeiter/innen: Diem Stefan
Vaccine and immunotherapy induced CD8+ T cell responses against auto-, neo- and foreign antigens
01.01.2016The growing incidence of melanoma is an increasing threat, and effective treatment options for advanced forms of melanoma are scarce. Although recently approved targeted- and immunotherapies have shown objective beneficial effects in metastatic melan...
Grundlagenforschung - 01.01.2016 - 31.12.2019
Automatisch geschlossen
Projektleitung: Flatz Lukas
Mitarbeiter/innen: Ring Sandra, Królik Michał Wojciech, Berner Fiamma